SCOPUS 정보 검색 플랫폼

Volumn 338, Issue 10, 2005, Pages 484-487

Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes

(6) Al Qahtani, Ahmed a,b Siddiqui, Yunus M b Bekhit, Adnan A c El Sayed, Ola A c Aboul Enein, Hassan Y b Al Ahdal, Mohammed N b

a KING SAUD UNIVERSITY (Saudi Arabia)

b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER (Saudi Arabia)

c Alexandria University Faculty of Pharmacy (Egypt)

Author keywords

Antileishmania; Antiparasite; Pyrazoloquinoline

Indexed keywords

AMPHOTERICIN B; PYRAZOLE DERIVATIVE; PYRAZOLOQUINOLINE DERIVATIVE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; GROWTH INHIBITION; LEISHMANIA DONOVANI; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; ANTIPROTOZOAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; LEISHMANIA DONOVANI; PYRAZOLES; QUINOLINES;

EID: 27644522773 PISSN: 03656233 EISSN: None Source Type: Journal
DOI: 10.1002/ardp.200500147 Document Type: Article

Times cited : (15)

References (19)

1
- 0026592139
- P. Desjeux, World Health Stat. Q. 1992, 45, 267-275.
- (1992) World Health Stat. Q. , vol.45 , pp. 267-275
- Desjeux, P.¹

2
- 0026533657
- J. Alexander, D. G. Russell, Adv. Parasitol. 1992, 31, 175-254.
- (1992) Adv. Parasitol. , vol.31 , pp. 175-254
- Alexander, J.¹ Russell, D.G.²

3
- 0024390249
- D. L. Sacks, Exp. Parasitol. 1989, 69, 100-103.
- (1989) Exp. Parasitol. , vol.69 , pp. 100-103
- Sacks, D.L.¹

4
- 0033517487
- B. L. Herwaldt, Lancet 1999, 354, 1191-1199.
- (1999) Lancet , vol.354 , pp. 1191-1199
- Herwaldt, B.L.¹

5
- 0036240055
- S. L. Croft, V. Yardley, Curr. Pharm. Des. 2002, 8, 319-342.
- (2002) Curr. Pharm. Des. , vol.8 , pp. 319-342
- Croft, S.L.¹ Yardley, V.²

6
- 0034780949
- S. Sundar, Trop. Med. Int. Health 2001, 6, 849-854.
- (2001) Trop. Med. Int. Health , vol.6 , pp. 849-854
- Sundar, S.¹

7
- 0036319712
- P. J. Guerin, P. Olliaro, S. Sundar, M. Boelaert, S. L. Croft, P. Desjeux, M. K. Wasunna, A. D. Bryceson, Lancet Infect. Dis. 2002, 2, 494-501.
- (2002) Lancet Infect. Dis. , vol.2 , pp. 494-501
- Guerin, P.J.¹ Olliaro, P.² Sundar, S.³ Boelaert, M.⁴ Croft, S.L.⁵ Desjeux, P.⁶ Wasunna, M.K.⁷ Bryceson, A.D.⁸

8
- 0001340977
- Therapy in Man
- (Ed.: P. W. Killick, and R. Kendrick), Academic Press Ltd., London
- A. D. M. Bryceson, Therapy in Man, in Leishmaniasis in Biology and Medicine (Ed.: P. W. Killick, and R. Kendrick), Academic Press Ltd., London, 1987, 848-907.
- (1987) Leishmaniasis in Biology and Medicine , pp. 848-907
- Bryceson, A.D.M.¹

9
- 0032491222
- A. X. Wang, Q. Xie, B. Lane, K. W. Mollison, G. C. Hsieh, K. Marsh, M. P. Sheets, J. R. Luly, M. J. Coghlan, Bioorg. Med. Chem. Lett. 1998, 8, 2787-2792.
- (1998) Bioorg. Med. Chem. Lett. , vol.8 , pp. 2787-2792
- Wang, A.X.¹ Xie, Q.² Lane, B.³ Mollison, K.W.⁴ Hsieh, G.C.⁵ Marsh, K.⁶ Sheets, M.P.⁷ Luly, J.R.⁸ Coghlan, M.J.⁹

10
- 17844405583
- A. A. Bekhit, O. A. El-Sayed, H. Y. Aboul-Enein, Y. M. Siddiqui, M. N. Al-Ahdal, Arch. Pharm. Pharm. Med. Chem. 2005, 338, 74-77.
- (2005) Arch. Pharm. Pharm. Med. Chem. , vol.338 , pp. 74-77
- Bekhit, A.A.¹ El-Sayed, O.A.² Aboul-Enein, H.Y.³ Siddiqui, Y.M.⁴ Al-Ahdal, M.N.⁵

11
- 1242307792
- A. A. Bekhit, O. A. El-Sayed, H. Y. Aboul-Enein, Y.-M. Siddiqui, M. N. Al-Ahdal, J. Enzyme Inhib. Med. Chem. 2004, 19, 33-38.
- (2004) J. Enzyme Inhib. Med. Chem. , vol.19 , pp. 33-38
- Bekhit, A.A.¹ El-Sayed, O.A.² Aboul-Enein, H.Y.³ Siddiqui, Y.-M.⁴ Al-Ahdal, M.N.⁵

12
- 18044404613
- C. S. Lee, D. A. Allwine, M. R. Barbachyn, K. C. Grega, L. A. Dolak, C. W. Ford, R. M. Jensen et al., Bioorg. Med. Chem. 2001, 9, 3243-3253.
- (2001) Bioorg. Med. Chem. , vol.9 , pp. 3243-3253
- Lee, C.S.¹ Allwine, D.A.² Barbachyn, M.R.³ Grega, K.C.⁴ Dolak, L.A.⁵ Ford, C.W.⁶ Jensen, R.M.⁷

13
- 0036132511
- P. G. Baraldi, M. G. M. G. Pavani, M. C. Nunez, P. Brigidi, B. Vitali, R. Gambari, R. Romagnoli, Bioorg. Med. Chem. 2002, 10, 449-456.
- (2002) Bioorg. Med. Chem. , vol.10 , pp. 449-456
- Baraldi, P.G.¹ Pavani, M.G.M.G.² Nunez, M.C.³ Brigidi, P.⁴ Vitali, B.⁵ Gambari, R.⁶ Romagnoli, R.⁷

14
- 0036021859
- O. A. El-Sayed, N. S. Habib, H. Y. Aboul-Enein, B. Costa, A. Lucacchini, C. Martini, Arch. Pharm. Pharm. Med. Chem. 2002, 335, 207-212.
- (2002) Arch. Pharm. Pharm. Med. Chem. , vol.335 , pp. 207-212
- El-Sayed, O.A.¹ Habib, N.S.² Aboul-Enein, H.Y.³ Costa, B.⁴ Lucacchini, A.⁵ Martini, C.⁶

15
- 0035037566
- O. A. El-Sayed, H. Y. Aboul-Enein, Arch. Pharm. Pharm. Med. Chem. 2001, 334, 117-120.
- (2001) Arch. Pharm. Pharm. Med. Chem. , vol.334 , pp. 117-120
- El-Sayed, O.A.¹ Aboul-Enein, H.Y.²

16
- 0024161483
- M. Williams, M. F. Jarvis, Pharmacol. Biochem. Behav. 1988, 29, 433-441.
- (1988) Pharmacol. Biochem. Behav. , vol.29 , pp. 433-441
- Williams, M.¹ Jarvis, M.F.²

17
- 0027375696
- P. O. Ogbunude, M. M. Dzimiri, Int. J. Parasitol. 1993, 23, 803-807.
- (1993) Int. J. Parasitol. , vol.23 , pp. 803-807
- Ogbunude, P.O.¹ Dzimiri, M.M.²

18
- 0026995855
- P. O. Ogbunude, M. H. Al-Jaser, Drugs Exp. Clin. Res. 1992, 18, 423-426.
- (1992) Drugs Exp. Clin. Res. , vol.18 , pp. 423-426
- Ogbunude, P.O.¹ Al-Jaser, M.H.²

19
- 0030071339
- K. S. Khabar, F. Al-Zoghaibi, M. Dzimiri, M. Taha, A. Al-Tuwaijri, M. N. Al-Ahdal, J. Interferon Cytokine Res. 1996, 16, 31-33.
- (1996) J. Interferon Cytokine Res. , vol.16 , pp. 31-33
- Khabar, K.S.¹ Al-Zoghaibi, F.² Dzimiri, M.³ Taha, M.⁴ Al-Tuwaijri, A.⁵ Al-Ahdal, M.N.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.